TwitterLinkedin

Contact Us

  • Biopharma Excellence
  • News & Events
    • Industry News Articles
    • Press Releases
    • Webinars
    • Events
    • Blog
    • Podcasts
  • Resource Library
    • Thought Leadership
    • Fact Flyers
    • Case Studies
    • White Papers
    • Webinars
    • Infographics
    • Video & Animation
  • Careers
    • Life at PharmaLex
    • Current Opportunities
  • Training
Top Bar
Search
PharmaLex Logo
MENUMENU
  • PharmaLex Logo
  • PharmaLex Logo
  • About UsAbout Us
    • About Us
    • Management Team
    • Corporate Social Responsibility
    • What Our Clients Say About Us
  • Our Services
    • Discovery / Non-clinical
          • Go to Discovery / Non-clinical section >>

          • Strategy and Consulting

            • Integrated Product Development
            • Market Access
            • Scientific Advice
            • Statistics and Data Sciences
            • Toxicology Services
    • Clinical Development
          • Go to Clinical Development section >>

          • Strategy and Consulting

            • Clinical Program Development
            • Scientific Advice
            • Statistics and Data Sciences
          • Regulatory Affairs

            • Clinical Trial Applications
            • Global Procedure Management
            • Health Authority / Agency Interaction
            • Regulatory Operations
          • Pharmacovigilance

            • Clinical Trial Safety Support
            • Pharmacovigilance Consulting
          • Quality

            • GxP Services
            • Interim / Contract QA
            • Quality Management Systems
            • Tech Transfer / Scale-up
    • Authorization / Approval
          • Go to Authorization / Approval section >>

          • Strategy and Consulting

            • Market Access
          • Regulatory Affairs

            • CMC Services
            • Global Procedure Management
            • Health Authority / Agency Interaction
            • Marketing and Labeling Activities
            • Regulatory Operations
            • Scientific, Regulatory and Technical Writing
            • Statistics and Data Sciences
          • Pharmacovigilance

            • EU QPPV / National QPPV
            • Pharmacovigilance Consulting
          • Quality

            • Commercialization Readiness
            • Commissioning, Qualification, and Validation (CQV)
            • GxP Services
            • Interim / Contract QA
            • PAI Readiness
    • Post-approval / Maintenance
          • Go to Post-approval / Maintenance section >>

          • Strategy and Consulting

            • Market Access
          • Regulatory Affairs

            • CMC Services
            • Global End-to-End Outsourcing
            • Global Procedure Management
            • Health Authority / Agency Interaction
            • Marketing and Labeling Activities
            • Mergers and Acquisitions (M&A) Transfers
            • Regulatory Operations
            • Toxicology Services
          • Pharmacovigilance

            • EU QPPV / National QPPV
            • ICSR (Individual Safety Case Report) Management
            • Literature Monitoring & Screening
            • Pharmacovigilance Quality & Compliance
            • Signal Management
          • Quality

            • Commissioning, Qualification, and Validation (CQV)
            • GxP Services
            • Interim / Contract QA
            • Quality Management Systems
          • Medical Affairs

            • Healthcare Compliance and Medical Approval
    • Program Management
          • Go to Program Management section >>

          • Program Management

            • Global End-to-End Outsourcing
            • Global Procedure Management
            • Integrated Product Development
            • Mergers and Acquisitions (M&A) Transfers
    • Featured Expertise
          • Industry Expertise

            • Biopharmaceuticals
            • MedTech Services
          • Service Expertise

            • ATMP / Cell and Gene Therapy
            • COVID-19 Support
            • GxP Services
            • Market Access
            • Pharmacovigilance Consulting
            • Post-Brexit Regulatory Support
            • Statistics and Data Sciences
            • SMARTPHLEX - technology-enabled services
  • Global ReachGlobal Reach
  • Contact usContact us
  • News & Events
    • Industry News Articles
    • Press Releases
    • Webinars
    • Events
    • Blog
    • Podcasts
  • Resource Library
    • Thought Leadership
    • Fact Flyers
    • Case Studies
    • White Papers
    • Webinars
    • Infographics
    • Video & Animation
  • Careers
    • Life at PharmaLex
    • Career Opportunities
  • Training
Home > SMARTPHLEX > SMARTVIGICONTRACT

SMARTVIGICONTRACT

Efficient management of PV contracts

SMARTVIGICONTRACT is a cloud-based software solution for pharmacovigilance teams who need to handle large amounts of data deriving from contracts, such as Pharmacovigilance Agreements (PVAs) and Safety Data Exchange Agreements (SDEAs).

The SMARTVIGICONTRACT application serves as a single trusted source of information for generation of PVA overviews.

Features

  • Central management of your PVA data
  • Contract status oversight (e.g. active, due for update, negotiation, termination etc.)
  • User-friendly and consistent data entry and retrieval
  • Increased data quality with consistency and plausibility checks
  • Secure access control (read / write / report access)

Benefits

  • Provides immediate oversight of the PV partner landscape within the PV system
  • Accelerates PVA management by user-friendly data entry, intuitive application and pre-set plausibility checks
  • Improves communication and data exchange with interfaces (e.g. legal or regulatory departments)
  • Increases efficiency and compliance with standard / ad-hoc reports

To find out more or request a demonstration

CONTACT US

Related News

Signal detection – the complete guide
Signal detection – the complete guide
3rd August 2021
PharmaLex expands APAC region
PharmaLex expands APAC region
23rd April 2021
PharmaLex expands France BENELUX region
PharmaLex expands France BENELUX region
16th March 2021

Related Resources

Fact Flyers

  • Signal Management Activities Customization
  • SMARTVIGILIT - Flyer
  • SMARTVIGICONTRACT - Flyer
  • SMARTVIGISCREEN - Flyer
  • Pharmacovigilance Services postcard

Case Studies

  • Case Processing Services
  • Support with retrieval of ICSR Follow-Up information
  • Global PV Outsourcing
  • Full PV Outsourcing of a Global Generics Pharma Company
  • Safety Detection and Signal Management
  • Outsourcing pharmacovigilance activities to PharmaLex
  • Safety Writing Services
  • Aggregate Report Writing and RMPs
  • Remediation Activities and Operational Support
  • Full service Post-Marketing Pharmacovigilance and Medical Information Services for large nutritional health company
  • Full service post-marketing and clinical trial PV activities for mid-sized pharma company
  • Dendritic cell vaccine (oncology)
  • Portfolio Maintenance Outsourcing – Global RA responsibility
  • Strategic outsourcing of mature product portfolio
  • Post–M&A PharmaLex program governance
  • Post–M&A pharma infrastructure development
  • Full PV service outsourcing

White Papers

  • Managing mature product portfolios - Key challenges and benefits
  • Preparing for a Good Pharmacovigilance Practice MHRA Inspection
  • UK Pharmacovigilance Requirements Following the End of the Brexit Transition Period

Webinars

  • Eudravigilance: overcoming challenges and gaining efficiencies with SMARTVIGISCREEN
  • EudraVigilance – The fundamental tool for Pharmacovigilance

Related Services

  • Clinical Trial Safety Support
  • EU QPPV / National QPPV
  • ICSR (Individual Safety Case Report) Management
  • Literature Monitoring & Screening
  • Pharmacovigilance Consulting
  • Pharmacovigilance Systems
  • SMARTPHLEX
  • SMARTVIGILIT
  • SMARTVIGISCREEN
Biopharma Excellence Website Image

PharmaLex Brings You Biopharma Excellence

Biopharma Excellence is a fusion of three scientific powerhouses, PharmaLex, ERA Consulting and Biopharma Excellence – all under the PharmaLex brand. This global team of scientific, regulatory and commercial professionals provide strategic product development and proactive regulatory services to developers of biopharmaceuticals, cell and gene therapies, monoclonal antibodies (MABs), vaccines and biosimilars.

Visit Website
USEFUL LINKS
  • Home
  • Contact us
  • Imprint
  • Data Protection
  • Terms and Conditions
RECENT TWEETS
PharmaLexGLOBALPharmaLex@PharmaLexGLOBAL·
24 Jun

Milena Shuytsova-Mircheva and Lisa Pascoe latest blog here https://www.pharmalex.com/sponsors-gear-up-for-a-smoother-process-with-ctis-but-must-first-overcome-key-hurdles/ discusses the benefit of the Clinical Trial Information System (CTIS).

💡 Interested in CTIS? Take the Phlexglobal survey to evaluate your preparation https://www.phlexglobal.com/ctis-survey

COVID-19 NEWSLETTER SIGN UP

SIGN UP NOW

WHAT OUR CLIENTS SAY
  • Pharmalex provided the resources we needed to compile Investigational Medicinal Product Dossiers for our biological products. The dossiers were delivered on time with the trusted quality we expected

    Small US Biopharmaceutical Company
    Sr Director Regulatory Affairs CMC
PharmaLex
©2022 PharmaLex GmbH. All rights reserved.

ISO9001:2015 LogoEnergie Audit LogoSGS Logo

Suspicious Emails

We are aware of a number of suspicious emails about recruitment in circulation purporting to be from PharmaLex. Emails sent by PharmaLex will originate from @pharmalex.com. Should you receive an email and are unsure as to its validity, please report it to contact@pharmalex.com.

Many thanks for your understanding.

The PharmaLex Team

    Please DO NOT send us event/conference information.
    We will not respond and these will be deleted immediately.






    Select your state:

    .
    If you do not wish to receive any communication from us, you may unsubscribe at any time.

    #AskTheExpert #TogetherBEYONDCOVID19





      Select your state:

      .
      You can unsubscribe at any time at data.protection@pharmalex.com

      If you do not wish to receive any communication from us, you can unsubscribe at any time at. Click here to view our Privacy Policy.

      #TogetherBEYONDCOVID19

      We closely monitor developments and updates surrounding the current outbreak of Coronavirus Disease 2019 (COVID-19) from official sources including the World Health Organisation and are following the guidance and direction of the governments and the local authorities. We are taking this situation very seriously and our number one priority is the safety and business continuity for our customers and colleagues. As ever, we will do everything we can to ensure that services are delivered within the required time and the trusted quality PharmaLex is known for